Graticule Asia Macro Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Graticule Asia Macro Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4K	Buy	+336	New	+$11.2K	﹤0.01%	196

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Graticule Asia Macro Advisors's TEVA Position: Q2 2026 in Review

Graticule Asia Macro Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 336 shares worth $11.4K. The stake represents ﹤0.01% of the portfolio and ranks #196 among its holdings.

672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Graticule Asia Macro Advisors held 336 shares of Teva Pharmaceuticals worth $11.4K as of Q2 2026.
Teva Pharmaceuticals was a new Graticule Asia Macro Advisors position in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Graticule Asia Macro Advisors's portfolio in Q2 2026, its #196 holding.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.